Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RHYTHM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 549,020 shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $58.8M as of 2025-Q4. The position was increased (++25.5% shares). RYTM represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$58.8M
Current Shares
549,020
Total Value Change
+$49.1M
Total Shares Change
+312,589
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC
Increased |
| 549,020 |
+25.5% |
| $58.8M |
| 0.0% |
| $106.76 |
36 |
| 2025-Q3 | Increased | 437,472 | +92.2% | $44.2M | 0.0% | $100.64 | 46 |
| 2025-Q2 | Increased | 227,627 | +81.0% | $14.4M | 0.0% | $62.73 | 43 |
| 2025-Q1 | Decreased | 125,782 | -42.5% | $6.7M | 0.0% | $54.80 | 0 |
| 2024-Q4 | Decreased | 218,544 | -3.0% | $12.2M | 0.0% | $56.34 | 0 |
| 2024-Q3 | Decreased | 225,373 | -4.7% | $11.8M | 0.0% | $51.35 | 0 |
| 2024-Q2 | Increased | 236,431 | +14.2% | $9.7M | 0.0% | $41.06 | 32 |